does tirzepatide increase insulin vs. Semaglutide: What You Should Know The Science Behind Tirzepatide: GLP-1

The study, published in The New England Journal of Medicine , suggests Zepbounds dual-action approach targeting both GLP-1 and GIP receptors may offer an added advantage in supporting long-term weight loss

Will and I met on a pickleball court in Charlotte what followed were golf rounds in Florida and Colorado, a lot of honest conversations about what we really wanted to build, and eventually a shared vision we couldn't ignore

Salehi S, Naghib SM, Garshasbi HR, Ghorbanzadeh S, Zhang W

The 2026 update that changes the math In April 2026, the FDA approved a higher-dose semaglutide 7.2 mg (Wegovy HD)

The take-home message is to follow up with your provider, and please start to dig into what might be going on because its important to try to rule out other things.